Table 1.
Patient, population or Problem | Intervention | Comparison | Outcome |
---|---|---|---|
What are the characteristics of the patients or population? | What interventions are we considering? | What is the alternative to the intervention? | What are the relevant outcomes? |
Psychotic disorders, including schizophrenia, bipolar disorder and schizophrenia-spectrum psychotic disorders with hyperprolactinaemia. | Four strategies for lowering prolactin: Switching antipsychotics Adding aripiprazole Adding other dopamine agonists (e.g., cabergoline, bromocriptine) Adding metformin |
Placebo or maintaining antipsychotic treatment (randomized clinical trials with comparison arms will be included in the meta-analysis). Uncontrolled studies (with comparator) will be included in the systematic review if there is information regarding changes in prolactin with the strategy. |
Reduction in prolactin plasma concentrations. |